Exploring the modulation of Antioxidant Metabolism to target Adult T-Cell Leukaemia Induced by HTLV-1 Infection

Project Code

MRCIIAR25Br Shytaj

Research Theme

Infection, Immunity, Antimicrobial Resistance and Repair

Project Summary Download

Summary

Human T-lymphotropic virus 1 (HTLV-1) causes lifelong infections and can lead to severe diseases like adult T-cell leukaemia/lymphoma (ATL), with limited treatment options. Our preliminary evidence shows HTLV-1 disrupts cellular metabolism, increasing oxidative stress to support rapid cell multiplication, potentially making infected cells reliant on antioxidant responses for their survival. This project aims to study the interplay between antioxidant metabolism and cell fate in the context of ATL. The final aim of the project is identify key antioxidant pathways crucial for ATL survival and test potential therapies in cell models to selectively eliminate infected tumor cells.

Lead Supervisor

Dr Iart Luca Shytaj

Lead Supervisor Email

luca.shytaj@bristol.ac.uk

University Affiliation

Bristol